Osciflex
Philadelphia
About Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots. Osciflex developing a more effective compression therapy device that can better prevent Venous thromboembolism (VTE) in patients and reduce the use of expensive and risky anti-coagulation pharmaceuticals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.2M
- Last round: Grant (Dec 2021)
- Website: osciflex.com
- Phone: (609) 977-7258
Industries & Categories
Health Care, Medical, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/osciflex-38059 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.